BC

Birchview Capital Portfolio holdings

AUM $101M
1-Year Return 34.62%
This Quarter Return
+12.02%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$142M
AUM Growth
+$4.53M
Cap. Flow
+$1.44M
Cap. Flow %
1.01%
Top 10 Hldgs %
70.5%
Holding
66
New
2
Increased
5
Reduced
4
Closed
2

Top Buys

1
PRTA icon
Prothena Corp
PRTA
$994K
2
BDSX icon
Biodesix
BDSX
$709K
3
VTYX icon
Ventyx Biosciences
VTYX
$419K
4
SRPT icon
Sarepta Therapeutics
SRPT
$276K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$180K

Top Sells

1
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$602K
2
CGEM icon
Cullinan Oncology
CGEM
$256K
3
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
$225K
4
FHTX icon
Foghorn Therapeutics
FHTX
$172K
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$40.8K

Sector Composition

1 Healthcare 93.28%
2 Energy 4.01%
3 Consumer Staples 0.08%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DCGO icon
26
DocGo
DCGO
$148M
$1.09M 0.77%
110,000
– –
CCXI
27
DELISTED
ChemoCentryx, Inc.
CCXI
$1.03M 0.73%
20,000
– –
ETRN
28
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$995K 0.7%
133,050
– –
TSVT
29
DELISTED
2seventy bio
TSVT
$871K 0.61%
59,833
– –
PXD
30
DELISTED
Pioneer Natural Resource Co.
PXD
$823K 0.58%
3,800
– –
APLS icon
31
Apellis Pharmaceuticals
APLS
$3.62B
$820K 0.58%
12,000
– –
NARI
32
DELISTED
Inari Medical, Inc. Common Stock
NARI
$726K 0.51%
10,000
– –
IMGN
33
DELISTED
Immunogen Inc
IMGN
$717K 0.5%
150,000
– –
ARVN icon
34
Arvinas
ARVN
$559M
$667K 0.47%
15,000
– –
BLUE
35
DELISTED
bluebird bio
BLUE
$620K 0.44%
4,900
– –
KALV icon
36
KalVista Pharmaceuticals
KALV
$765M
$580K 0.41%
40,000
– –
IRTC icon
37
iRhythm Technologies
IRTC
$5.85B
$501K 0.35%
4,000
– –
GTHX
38
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$500K 0.35%
40,000
– –
SILK
39
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$450K 0.32%
10,000
– –
ISEE
40
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$449K 0.32%
25,000
+10,000
+67% +$180K
NKTR icon
41
Nektar Therapeutics
NKTR
$684M
$410K 0.29%
8,533
– –
SLNO icon
42
Soleno Therapeutics
SLNO
$3.7B
$409K 0.29%
245,127
– –
FOLD icon
43
Amicus Therapeutics
FOLD
$2.47B
$397K 0.28%
38,000
– –
KNSA icon
44
Kiniksa Pharmaceuticals
KNSA
$2.63B
$385K 0.27%
30,000
– –
XENE icon
45
Xenon Pharmaceuticals
XENE
$2.98B
$361K 0.25%
10,000
– –
CGEM icon
46
Cullinan Oncology
CGEM
$408M
$322K 0.23%
25,114
-20,000
-44% -$256K
PTGX icon
47
Protagonist Therapeutics
PTGX
$3.71B
$320K 0.23%
38,000
– –
XNCR icon
48
Xencor
XNCR
$597M
$320K 0.23%
12,300
– –
SRPT icon
49
Sarepta Therapeutics
SRPT
$1.93B
$276K 0.19%
+2,500
New +$276K
BCRX icon
50
BioCryst Pharmaceuticals
BCRX
$1.74B
$252K 0.18%
20,000
– –
1
2
3